Enlivex Therapeutics Ltd. (ENLV) Earnings
|
Expand Research on ENLV
| Next EPS Date | 5/24/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +46.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/24/24 | Q124 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/28/24 | Q423 | N/A | -$0.28 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.46 | N/A | N/A | N/A | N/A | N/A | N/A |
